BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22467474)

  • 1. Neural stem cells directly differentiated from partially reprogrammed fibroblasts rapidly acquire gliogenic competency.
    Matsui T; Takano M; Yoshida K; Ono S; Fujisaki C; Matsuzaki Y; Toyama Y; Nakamura M; Okano H; Akamatsu W
    Stem Cells; 2012 Jun; 30(6):1109-19. PubMed ID: 22467474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oct4-induced pluripotency in adult neural stem cells.
    Kim JB; Sebastiano V; Wu G; Araúzo-Bravo MJ; Sasse P; Gentile L; Ko K; Ruau D; Ehrich M; van den Boom D; Meyer J; Hübner K; Bernemann C; Ortmeier C; Zenke M; Fleischmann BK; Zaehres H; Schöler HR
    Cell; 2009 Feb; 136(3):411-9. PubMed ID: 19203577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural stem cells derived from epiblast stem cells display distinctive properties.
    Jang HJ; Kim JS; Choi HW; Jeon I; Choi S; Kim MJ; Song J; Do JT
    Stem Cell Res; 2014 Mar; 12(2):506-16. PubMed ID: 24463498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
    Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
    Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of in vivo neural stem cells using partially reprogrammed cells defective in in vitro differentiation potential.
    Kim JS; Hong YJ; Choi HW; Song H; Byun SJ; Do JT
    Oncotarget; 2017 Mar; 8(10):16456-16462. PubMed ID: 28147316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sox2 expression defines a heterogeneous population of neurosphere-forming cells in the adult murine brain.
    Brazel CY; Limke TL; Osborne JK; Miura T; Cai J; Pevny L; Rao MS
    Aging Cell; 2005 Aug; 4(4):197-207. PubMed ID: 16026334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
    Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
    Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression.
    Eminli S; Utikal J; Arnold K; Jaenisch R; Hochedlinger K
    Stem Cells; 2008 Oct; 26(10):2467-74. PubMed ID: 18635867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons.
    Rössler R; Boddeke E; Copray S
    Neuroscience; 2010 Oct; 170(2):417-28. PubMed ID: 20643196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of genomic imprinting by reprogramming and redifferentiation.
    Kim MJ; Choi HW; Jang HJ; Chung HM; Arauzo-Bravo MJ; Schöler HR; Do JT
    J Cell Sci; 2013 Jun; 126(Pt 11):2516-24. PubMed ID: 23525019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
    Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
    Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
    Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
    Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct conversion of fibroblasts into stably expandable neural stem cells.
    Thier M; Wörsdörfer P; Lakes YB; Gorris R; Herms S; Opitz T; Seiferling D; Quandel T; Hoffmann P; Nöthen MM; Brüstle O; Edenhofer F
    Cell Stem Cell; 2012 Apr; 10(4):473-9. PubMed ID: 22445518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic chromosomal analysis of cultured mouse neural stem cell lines.
    Diaferia GR; Conti L; Redaelli S; Cattaneo M; Mutti C; DeBlasio P; Dalprà L; Cattaneo E; Biunno I
    Stem Cells Dev; 2011 Aug; 20(8):1411-23. PubMed ID: 21275879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural stem cells are increased after loss of β-catenin, but neural progenitors undergo cell death.
    Holowacz T; Huelsken J; Dufort D; van der Kooy D
    Eur J Neurosci; 2011 Apr; 33(8):1366-75. PubMed ID: 21375603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reprogramming of adult cells to neurons].
    Mikkelsen JD; Rasmussen MA; Meyer M; Knudsen GM
    Ugeskr Laeger; 2012 Mar; 174(12):786. PubMed ID: 22433543
    [No Abstract]   [Full Text] [Related]  

  • 17. Generation and characterization of reprogrammed sheep induced pluripotent stem cells.
    Liu J; Balehosur D; Murray B; Kelly JM; Sumer H; Verma PJ
    Theriogenology; 2012 Jan; 77(2):338-46.e1. PubMed ID: 21958637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolation and cultivation of neural stem cells from the embryonic rat brain and spinal cord].
    Fu SL; Ma ZW; Yin L; Lu PH; Xu XM
    Sheng Li Xue Bao; 2003 Jun; 55(3):278-83. PubMed ID: 12817294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Exploring the neural diseases using stem cell technology].
    Akamatsu W
    Rinsho Shinkeigaku; 2012; 52(11):937-8. PubMed ID: 23196475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.